Fact check
“The GAO report found that the FDA does not have policies or procedures that clearly define the criteria and process for determining a substance's potential for abuse.”
Reasoning
The evidence excerpt from a reputable source cites the GAO report and includes the exact language stating that the FDA does not have policies or procedures that clearly define the criteria and process for determining a substance's potential for abuse. This directly supports the claim.
On confidence: The provided excerpt directly quotes the GAO report's finding that the FDA lacks written policies or procedures defining criteria and process for determining a substance's potential for abuse.
Important context
The GAO (Government Accountability Office) evaluated the FDA's scheduling procedures and identified the absence of clear written standards for assessing abuse potential, which is the basis of the claim.
Evidence
Supporting (1)
- Tier 1 — Primary sourceThe way the FDA and DEA ban drugs is unaccountable and arbitrary
you'd think officials actually know the content of the most critical of those laws. The problem is not just localized to the DEA. Given the FDA's role in reaching scheduling decisions, the GAO also examined that agency's procedures and…
Limitations
The assessment relies on a single secondary source summarizing the GAO report; the original GAO document was not directly accessed, so verification is limited to the accuracy of the quoted excerpt. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.
- Last verified:
- Oct 1, 2026, 4:11 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
The Way the FDA and DEA Ban Drugs Is Unaccountable and ArbitraryReason · Ryan Curtis